Single-cell sequencing in ovarian cancer: A new frontier in precision medicine

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Purpose of reviewThis article discusses the advances, applications and challenges of using single-cell RNA sequencing data in guiding treatment decisions for ovarian cancer.Recent findingsGenetic heterogeneity is a hallmark of ovarian cancer biology and underlies treatment resistance. Defining the different cell types present within a single ovarian cancer is difficult, but could ultimately lead to improvements in diagnosis and treatment. Next-generation sequencing technologies have rapidly increased our understanding of the molecular landscape of epithelial ovarian cancers, but the majority of these studies are conducted on bulk samples, resulting in data that represents an 'average' of all cells present. Single-cell sequencing provides a means to characterize heterogeneity with a tumor tissue in ovarian cancer patients and opens up opportunity to determine key molecular properties that influence clinical outcomes, including prognosis and treatment response.SummarySingle-cell sequencing provides a powerful tool in improving our understanding of tumor cell heterogeneity for the purpose of informing personalized cancer treatment.

Original languageEnglish (US)
Pages (from-to)49-55
Number of pages7
JournalCurrent Opinion in Obstetrics and Gynecology
Issue number1
StatePublished - Feb 1 2019


  • ovarian cancer
  • precision medicine
  • single-cell RNA sequencing

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

Fingerprint Dive into the research topics of 'Single-cell sequencing in ovarian cancer: A new frontier in precision medicine'. Together they form a unique fingerprint.

Cite this